Literature DB >> 22511267

MicroRNAs regulate p21(Waf1/Cip1) protein expression and the DNA damage response in human embryonic stem cells.

Dasa Dolezalova1, Marek Mraz, Tomas Barta, Karla Plevova, Vladimir Vinarsky, Zuzana Holubcova, Josef Jaros, Petr Dvorak, Sarka Pospisilova, Ales Hampl.   

Abstract

Studies of human embryonic stem cells (hESCs) commonly describe the nonfunctional p53-p21 axis of the G1/S checkpoint pathway with subsequent relevance for cell cycle regulation and the DNA damage response (DDR). Importantly, p21 mRNA is clearly present and upregulated after the DDR in hESCs, but p21 protein is not detectable. In this article, we provide evidence that expression of p21 protein is directly regulated by the microRNA (miRNA) pathway under standard culture conditions and after DNA damage. The DDR in hESCs leads to upregulation of tens of miRNAs, including hESC-specific miRNAs such as those of the miR-302 family, miR-371-372 family, or C19MC miRNA cluster. Most importantly, we show that the hESC-enriched miRNA family miR-302 (miR-302a, miR-302b, miR-302c, and miR-302d) directly contributes to regulation of p21 expression in hESCs and, thus, demonstrate a novel function for miR-302s in hESCS. The described mechanism elucidates the role of miRNAs in regulation of important molecular pathway governing the G1/S transition checkpoint before as well as after DNA damage.
Copyright © 2012 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22511267     DOI: 10.1002/stem.1108

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  49 in total

Review 1.  Epigenetic alterations in human parathyroid tumors.

Authors:  Chiara Verdelli; Irene Forno; Valentina Vaira; Sabrina Corbetta
Journal:  Endocrine       Date:  2015-02-27       Impact factor: 3.633

Review 2.  Molecular mechanisms controlling the cell cycle in embryonic stem cells.

Authors:  Essam M Abdelalim
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

Review 3.  Cellular senescence: from growth arrest to immunogenic conversion.

Authors:  D G A Burton; R G A Faragher
Journal:  Age (Dordr)       Date:  2015-03-20

Review 4.  MicroRNAs tune cerebral cortical neurogenesis.

Authors:  M-L Volvert; F Rogister; G Moonen; B Malgrange; L Nguyen
Journal:  Cell Death Differ       Date:  2012-08-03       Impact factor: 15.828

5.  Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.

Authors:  Vladimir Vinarsky; Jan Krivanek; Liina Rankel; Zuzana Nahacka; Tomas Barta; Josef Jaros; Ladislav Andera; Ales Hampl
Journal:  Stem Cells Dev       Date:  2013-08-02       Impact factor: 3.272

Review 6.  DNA repair mechanisms in embryonic stem cells.

Authors:  Xuemei Fu; Ke Cui; Qiuxiang Yi; Lili Yu; Yang Xu
Journal:  Cell Mol Life Sci       Date:  2016-09-10       Impact factor: 9.261

7.  Dicer1 Ablation Impairs Responsiveness of Cerebellar Granule Neuron Precursors to Sonic Hedgehog and Disrupts Expression of Distinct Cell Cycle Regulator Genes.

Authors:  Qian Liu; Mei Jiang; Yi Kuang; Xiaoqiong Shu; Jun Li; Matthew W Li; Hedong Li
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

8.  miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1.

Authors:  Marek Mraz; Liguang Chen; Laura Z Rassenti; Emanuela M Ghia; Hongying Li; Kristen Jepsen; Erin N Smith; Karen Messer; Kelly A Frazer; Thomas J Kipps
Journal:  Blood       Date:  2014-05-01       Impact factor: 22.113

9.  Tumoral NKG2D alters cell cycle of acute myeloid leukemic cells and reduces NK cell-mediated immune surveillance.

Authors:  Mingying Tang; Desmond Omane Acheampong; Youfu Wang; Wei Xie; Min Wang; Juan Zhang
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

10.  ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways.

Authors:  Qinhua Guo; Pin Guo; Qing Mao; Jin Lan; Yingying Lin; Jiyao Jiang; Yongming Qiu
Journal:  Med Oncol       Date:  2013-02-03       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.